September expectationsP1 efficacy data in sortilin overexpressed cancer types (in at least 2 cancer types)
Assurance or at least a path to assurance, that the efficacy effect is that of Th1902.
Quite simple to deliver.
Leadership is also showing up at cancer trial sites and making sure the P.I. is focused on patient accrual.